Zhejiang Shengda Bio-Pharm Co., Ltd.

SSE:603079.SS

16.62 (CNY) • At close June 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Revenue 827.402727.406738.019789.733867.315519.15492.71508.561482.148536.429380.897398.771449.254
Cost of Revenue 651.452653.221607.173561.272393.735326.62327.405316.247310.542262.502244.058263.06221.261
Gross Profit 175.9574.184130.846228.461473.579192.53165.305192.314171.606273.928136.839135.711227.993
Gross Profit Ratio 0.2130.1020.1770.2890.5460.3710.3360.3780.3560.5110.3590.340.507
Reseach & Development Expenses 43.76242.92537.41839.64335.68627.90121.38622.87823.90526.62421.03918.02823.146
General & Administrative Expenses 17.90815.1514.03234.89553.6825.64320.00318.38624.4661.03511.55462.658111.761
Selling & Marketing Expenses 6.7685.88913.24912.47228.58218.49617.12115.32919.75221.36514.9213.38124.911
SG&A 24.67677.2627.28247.36782.26244.13937.12433.71444.21282.426.47576.039136.672
Other Expenses 60.945-0.32543.94565.24974.27149.5381.077-0.83110.63-0.4230.26621.486-4.394
Operating Expenses 129.384119.206108.645152.259192.219121.578106.91388.751114.947153.74578.99879.438140.228
Operating Income 46.566-45.67659.41181.444247.30676.71152.29985.8263.453109.83950.57946.70974.842
Operating Income Ratio 0.056-0.0630.0810.1030.2850.1480.1060.1690.1320.2050.1330.1170.167
Total Other Income Expenses Net 2.5190.368-22.887-1.403-23.632-1.5060.10.1469.903-1.722-0.5320.336-5.198
Income Before Tax 49.085-45.30836.52480.042223.67449.17552.39985.96672.985108.11650.0567.04569.644
Income Before Tax Ratio 0.059-0.0620.0490.1010.2580.0950.1060.1690.1510.2020.1310.1680.155
Income Tax Expense 11.8288.8946.0848.21933.70211.4169.81513.35612.0521.4136.2649.95316.234
Net Income 29.424-54.06331.48475.756197.43847.0344.54472.6160.93686.70343.78554.59252.36
Net Income Ratio 0.036-0.0740.0430.0960.2280.0910.090.1430.1260.1620.1150.1370.117
EPS 0.17-0.320.180.441.170.30.290.560.520.740.370.490.47
EPS Diluted 0.17-0.320.180.441.170.30.290.560.520.740.370.490.47
EBITDA 126.08434.449114.417163.803302.855111.55992.102119.37191.441140.77780.90956.27387.766
EBITDA Ratio 0.1520.0470.1550.2070.3490.2150.1870.2350.190.2620.2120.1410.195